Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.7K
Design Consideration01:22

Design Consideration

580
Designing a structure involves a series of considerations, primarily the material's ultimate strength, calculated through tests that measure changes under increased force until the material reaches its breaking point or limit. The ultimate load, where the material breaks, is divided by its original cross-sectional area, resulting in the ultimate normal stress or strength. The ultimate shearing stress is another significant factor taken into account.
The factor of safety is another key...
580
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Transmission Line Design Considerations01:23

Transmission Line Design Considerations

631
Aluminum has become the material of choice for overhead transmission lines, surpassing copper due to its abundance and cost-effectiveness. The most prevalent type is the aluminum conductor, steel-reinforced (ACSR), which combines aluminum strands around a steel core. Other variants include all-aluminum conductors (AAC), all-aluminum alloy conductors (AAAC), aluminum conductor alloy-reinforced (ACAR), and aluminum-clad steel conductors. Advanced designs, such as aluminum conductors with steel...
631
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

424
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
424

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial.

JAMA·2026
Same author

PRO-ADD: Patient-empowered dose-finding trials integrating safety, preliminary efficacy and patient-reported outcomes for optimal dose selection.

Statistical methods in medical research·2026
Same author

Training for pediatric cannot intubate cannot oxygenate: surgical airway should replace needle cricothyrotomy.

Frontiers in disaster and emergency medicine·2026
Same author

PROSPECT-LUNG: A National Clinical Trials Network Trial Advancing Pragmatic Innovation in Cancer Clinical Trials.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Was It Worth It? Response Data from >650 US and International Participants in Chemoprevention Trials.

Cancer prevention research (Philadelphia, Pa.)·2025
Same author

Multiple concurrent opportunistic infections in patient with myasthenia gravis: A case report.

Virulence·2025
Same journal

Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough.

Therapeutic innovation & regulatory science·2026
Same journal

Understanding the Added Value of Action Limits for QTL Monitoring.

Therapeutic innovation & regulatory science·2026
Same journal

Implementing Project Optimus in Oncology Dosage Optimization: Where are We Now?

Therapeutic innovation & regulatory science·2026
Same journal

Validation of the Ontario Protocol Assessment Level (OPAL) Tool for Assessing Clinical Trial Complexity and Supporting Workforce Planning in the Italian Clinical Research Context.

Therapeutic innovation & regulatory science·2026
Same journal

The Effect of Covariate Adjustment for Cox Regression in Cardiovascular Outcome Trials.

Therapeutic innovation & regulatory science·2026
Same journal

Current Status and Construction Requirements of Drug Clinical Trial Institutions in Sichuan Province in China.

Therapeutic innovation & regulatory science·2026
See all related articles

Related Experiment Video

Updated: Feb 5, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Multipopulation Tailoring Clinical Trials: Design, Analysis, and Inference Considerations.

Brian A Millen1, Alex Dmitrienko2, Sumithra J Mandrekar3

  • 11 Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.

Therapeutic Innovation & Regulatory Science
|September 22, 2018
PubMed
Summary
This summary is machine-generated.

This study introduces a decision-making framework for multipopulation clinical trials, evaluating its error rates against standard hypothesis tests for better treatment effect analysis in diverse patient groups.

Keywords:
familywise error rateinfluence conditioninteraction conditionsubgroup analysistailored therapeutics

More Related Videos

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.3K
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.5K

Related Experiment Videos

Last Updated: Feb 5, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.3K
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.5K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmaceutical Research

Background:

  • Multipopulation clinical trials require careful statistical planning to assess treatment effects across diverse patient groups.
  • Evaluating treatment efficacy in both overall and specific subpopulations presents unique analytical challenges.
  • Existing methods may not adequately address the complexities of subgroup analyses in clinical trial settings.

Purpose of the Study:

  • To present a novel decision-making framework for statistical considerations in multipopulation clinical trials.
  • To evaluate the operating characteristics of this framework in comparison to traditional hypothesis testing approaches.
  • To quantify specific error rates, including influence and interaction errors, within these trial designs.

Main Methods:

  • Development of a decision-making framework tailored for multipopulation clinical trials.
  • Comparative analysis of the proposed framework's operating characteristics against standard primary hypothesis tests.
  • Assessment of influence errors and interaction errors as key performance metrics.

Main Results:

  • The proposed decision-making framework demonstrates distinct operating characteristics compared to methods relying solely on primary hypothesis tests.
  • Quantification of influence and interaction errors provides insights into the framework's performance.
  • The framework offers a structured approach to managing statistical complexities in multipopulation studies.

Conclusions:

  • The presented decision-making framework offers a valuable tool for navigating statistical challenges in multipopulation clinical trials.
  • Understanding and minimizing influence and interaction errors are crucial for accurate treatment effect evaluation.
  • This approach enhances the rigor of clinical trial design and analysis for diverse patient populations.